Neuroprotective effects of sodium orthovanadate after hypoxic-ischemic brain injury in neonatal rats

Brain Research Bulletin

Volumn 76, Issue 1-2, 2008, Pages 102-108

  Feng, Yangzheng ^a   Bhatt, Abhay J ^a   Fratkin, Jonathan D ^a   Rhodes, Philip G ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Akt PKB; Apoptosis; Neuroprotection; Newborn rat; Sodium orthovanadate

Indexed keywords

BROXURIDINE; GLUCOSE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; VANADATE SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN DAMAGE; BRAIN HYPOXIA; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN WEIGHT; CAROTID ARTERY LIGATION; CELL DENSITY; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG MECHANISM; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; NEUROPROTECTION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; RIGHT HEMISPHERE; SUBVENTRICULAR ZONE;

ANIMALS; ANIMALS, NEWBORN; BLOOD GLUCOSE; BODY TEMPERATURE; BODY WEIGHT; BRAIN; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; HYPOXIA-ISCHEMIA, BRAIN; NEUROPROTECTIVE AGENTS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; VANADATES;

EID: 41449096767     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2008.01.012     Document Type: Article

References (29)

1. Althaus J., Bernaudin M., Petit E., Toutain J., Touzani O., and Rami A. Expression of the gene encoding the pro-apoptotic BNIP3 protein and stimulation of hypoxia-inducible factor-1alpha (HIF-1alpha) protein following focal cerebral ischemia in rats. Neurochem. Int. 48 (2006) 687-695
2. Andine P., Thordstein M., Kjellmer I., Nordborg C., Thiringer K., Wennberg E., and Hagberg H. Evaluation of brain damage in rat model of neonatal hypoxic ischemia. J. Neurosci. Methods 35 (1990) 253-260
3. Brichard S.M., and Henquin J.C. The role of vanadium in the management of diabetes. Trends Pharmacol. Sci. 16 (1995) 265-270
4. Brunet A., Datta S.R., and Greenberg M.E. Transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway. Curr. Opin. Neurobiol. 11 (2001) 297-305
5. Cataltepe O.V.R., Heitjan D.F., and Towfighi J. Effect of status epilepticus on hypoxic-ischemic brain damage in the immature rat. Pediatr. Res. 38 (1995) 251-257
6. Du K., and Montminy M. CRBE is a regulatory target for the protein kinase Akt/PKB. J. Biol. Chem. 273 (1998) 32377-32379
7. du Plessis A.J., and Volpe J.J. Perinatal brain injury in the preterm and term newborn. Curr. Opin. Neurol. 15 (2002) 151-157
8. Elberg G., Li J., and Shechter Y. Vanadium activates or inhibits receptor and non-receptor protein tyrosine kinases in cell-free experiments, depending on its oxidation state: possible role of endogenous vanadium in controlling cellular protein tyrosine kinase activity. J. Biol. Chem. 269 (1994) 9521-9527
9. Feng Y., Fratkins J.D., and LeBlanc M.H. Treatment with tamoxifen reduces hypoxic-ischemic brain injury in neonatal rats. Eur. J. Pharmacol. 484 (2004) 65-74
10. Franke T.F., Hornik C.P., Segev L., Shostak G.A., and Sugimoto C. PI3K/Akt and apoptosis: size matters. Oncogene 22 (2003) 8983-8998
11. Franke T.F., Kaplan D.R., and Cantley L.C. PI3K: downstream AKTion blocks apoptosis. Cell 88 (1977) 435-437
12. Gao N., Ding M., Zheng J.Z., Zhang Z., Leonard S.S., Liu K.J., Shi X., and Jiang B.H. Vanadate-induced expression of hypoxia-inducible factor 1 alpha and vascular endothelial growth factor through phosphatidylinositol 3-kinase/Akt pathway and reactive oxygen species. J. Biol. Chem. 277 (2002) 31963-31971
13. Hasegawa Y., Hamada J., Morioka M., Yano S., Kawano T., Kai Y., Fukunaga K., and Ushio Y. Neuroprotective effect of post ischemic administration of sodium orthovanadate in rats with transient middle cerebral artery occlusion. J. Cereb. Blood Flow Metab. 23 (2003) 1040-1051
14. Hasegawa Y., Morioka M., Hasegawa S., Matsumoto J., Kawano T., Kai Y., Yano S., Fukunaga K., and Kuratsu J.I. Therapeutic time window and dose dependence of neuroprotective effects of sodium orthovanadate following transient middle cerebral artery occlusion in rats. J. Pharmacol. Exp. Ther. 317 (2006) 875-881
15. Kawano T., Fukunaga K., Takeuchi Y., Morioka M., Yano S., Hamada J., Ushio Y., and Miyamoto E. Neuroprotective effect of sodium orthovanadate on delayed neuronal death after transient forebrain ischemia in gerbil hippocampus. J. Cereb. Blood Flow Metab. 21 (2001) 1268-1280
16. Lohmann C., Krischke M., Wegener J., and Galla H.J. Tyrosine phosphatase inhibition induces loss of blood-brain barrier integrity by matrix metalloproteinase-dependent and -independent pathways. Brain Res. 995 (2004) 184-196
17. Matsumoto J., Morioka M., Hasegawa Y., Kawano T., Yoshinaga Y., Maeda T., Yano S., Kai Y., Fukunaga K., and Kuratsu J. Sodium orthovanadate enhances proliferation of progenitor cells in the adult rat subventricular zone after focal cerebral ischemia. J. Pharmacol. Exp. Ther. 318 (2006) 982-991
18. Morita A., Zhu J., Suzuki N., Enomoto A., Matsumoto Y., Tomita M., Suzuki T., Ohtomo K., and Hosoi Y. Sodium orthovanadate suppresses DNA damage-induced caspase activation and apoptosis by inactivating p53. Cell Death Differ. 13 (2006) 499-511
19. Northington F.J., Graham E.M., and Martin L.J. Apoptosis in perinatal hypoxic-ischemic brain injury: how important is it and should it be inhibited?. Brain Res. Rev. 50 (2005) 244-257
20. Ong J., Plane J.M., Parent J.M., and Silverstein F.S. Hypoxic-ischemic injury stimulates subventricular zone proliferation and neurogenesis in the neonatal rat. Pediatr. Res. 58 (2005) 600-606
21. Palmer C., Vannucci R.C., and Towfighi J. Reduction of perinatal hypoxic-ischemic brain damage with allopurinol. Pediatr. Res. 27 (1990) 332-336
22. Ran R., Xu H., Lu A., Bernaudin M., and Sharp F.R. Hypoxia preconditioning in the brain. Dev. Neurosci. 27 (2005) 87-92
23. Rice J.E., Vannucci R.C., and Brierley J.B. The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann. Neurol. 9 (1981) 131-141
24. Romashkova J.A., and Makarov S.S. NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling. Nature 401 (1999) 86-90
25. Shrivastava K., Shukla D., Bansal A., Sairam M., Banerjee P.K., and Ilavazhagan G. Neuroprotective effect of cobalt chloride on hypobaric hypoxia-induced oxidative stress. Neurochem. Int. 52 (2008) 368-375
26. Srivastava A.K. Anti-diabetic and toxic effects of vanadium compounds. Mol. Cell Biochem. 206 (2000) 177-182
27. Sugano M., Tsuchida K., and Makino N. A protein tyrosine phosphatase inhibitor accelerates angiogenesis in a rat model of hind limb ischemia. J. Cardiovasc. Pharmacol. 44 (2004) 460-465
28. Yager J., Towfighi J., and Vannucci R.C. Influence of mild hypothermia on hypoxic-ischemic brain damage in the immature rat. Pediatr. Res. 34 (1993) 525-529
29. Zhao H., Shimohata T., Wang J.Q., Sun G., Schaal D.W., Sapolsky R.M., and Steinberg G.K. Akt contributes to neuroprotection by hypothermia against cerebral ischemia in rats. J. Neurosci. 25 (2005) 9794-9806